Sigma Planning Corp Galapagos Nv Transaction History

Sigma Planning Corp

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 03, 2020	SELL	$146.12 - $215.82 $247,819 - $366,030	-1,696 Closed	0 $0
Q3 2019 Nov 01, 2019	BUY	$130.44 - $187.64 $6,391 - $9,194	49 Added 2.98%	1,696 $259,000
Q2 2019 Aug 01, 2019	BUY	$111.45 - $128.93 $183,558 - $212,347	1,647 New	1,647 $212,000

17.4M

10.4K

33.1K

Ticker GLPG
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 65,835,500
Market Cap $1.93B
Description
Galapagos NV, an integrated biopharmaceutical company, engages in the discovery, development, and commercialization of various medicines for high unmet medical need. Its pipeline products include filgotinib, a JAK1 inhibitor that is in various phases of clinical trials for the treatment of rheumatoid arthritis, Crohn's disease, ulcerative coliti...

Get notified when there are updates to the investment portfolio of Sigma Planning Corp, based on Form 13F filings with the SEC.

Stay updated on Sigma Planning Corp with notifications on news.